CL2009000019A1 - Compuestos derivados de aril sulfonamida que contienen o-sulfato u o-fosfato; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso como profarmacos para incrementar la semivida de circulacion de compuestos inhibidores de la produccion de beta-amiloide, utiles en el tratamiento del alzheimer y cancer. - Google Patents
Compuestos derivados de aril sulfonamida que contienen o-sulfato u o-fosfato; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso como profarmacos para incrementar la semivida de circulacion de compuestos inhibidores de la produccion de beta-amiloide, utiles en el tratamiento del alzheimer y cancer.Info
- Publication number
- CL2009000019A1 CL2009000019A1 CL2009000019A CL2009000019A CL2009000019A1 CL 2009000019 A1 CL2009000019 A1 CL 2009000019A1 CL 2009000019 A CL2009000019 A CL 2009000019A CL 2009000019 A CL2009000019 A CL 2009000019A CL 2009000019 A1 CL2009000019 A1 CL 2009000019A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- sulfate
- phosphate
- alzheimer
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
- C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
Abstract
Composición farmacéutica que comprende un compuesto derivado de aril sulfonamida que contiene o-sulfato y o-fosfato; compuesto derivado de aril sulfonamida que contiene o-sulfato y o-fosfato; procedimiento de preparación; y uso como inhibidor de la producción de beta-amiloide en el tratamiento del Alzheimer y cáncer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1089408P | 2008-01-11 | 2008-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009000019A1 true CL2009000019A1 (es) | 2009-05-22 |
Family
ID=40467169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009000019A CL2009000019A1 (es) | 2008-01-11 | 2009-01-07 | Compuestos derivados de aril sulfonamida que contienen o-sulfato u o-fosfato; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso como profarmacos para incrementar la semivida de circulacion de compuestos inhibidores de la produccion de beta-amiloide, utiles en el tratamiento del alzheimer y cancer. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090181932A1 (es) |
AR (1) | AR070120A1 (es) |
CL (1) | CL2009000019A1 (es) |
PA (1) | PA8811701A1 (es) |
TW (1) | TW200934482A (es) |
WO (1) | WO2009089237A1 (es) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5889061A (en) * | 1997-10-15 | 1999-03-30 | Wisconsin Alumni Research Foundation | Conformationally restricted polyamines |
CN1263750C (zh) * | 2000-12-13 | 2006-07-12 | 惠氏 | β淀粉样蛋白产生的杂环磺酰胺类抑制剂 |
US6657070B2 (en) * | 2000-12-13 | 2003-12-02 | Wyeth | Production of chirally pure α-amino acids and N-sulfonyl α-amino acids |
BR0311767A (pt) * | 2002-06-11 | 2005-03-08 | Wyeth Corp | Compostos inibidores de sulfonamida substituìda da produção de beta amilóide, suas composições e usos |
KR20060002908A (ko) * | 2003-03-31 | 2006-01-09 | 와이어쓰 | 베타 아밀로이드 생산 억제제인 플루오로- 및트리플루오로알킬-함유 헤테로사이클릭 설폰아미드 및 이의유도체 |
CN1910158A (zh) * | 2004-01-16 | 2007-02-07 | 惠氏公司 | 含有氮杂环的β淀粉样蛋白生成的杂环磺酰胺抑制剂 |
CA2641013A1 (en) * | 2006-02-17 | 2007-08-30 | Wyeth | Methods for preparing sulfonamide substituted alcohols and intermediates thereof |
US7550629B2 (en) * | 2006-04-21 | 2009-06-23 | Wyeth | Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors |
TW200848019A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Aryl sulfonamides useful for modulation of the progesterone receptor |
CA2693959A1 (en) * | 2007-07-16 | 2009-01-22 | Wyeth | Inhibitors of beta amyloid production |
-
2009
- 2009-01-07 WO PCT/US2009/030254 patent/WO2009089237A1/en active Application Filing
- 2009-01-07 CL CL2009000019A patent/CL2009000019A1/es unknown
- 2009-01-07 PA PA20098811701A patent/PA8811701A1/es unknown
- 2009-01-07 TW TW098100349A patent/TW200934482A/zh unknown
- 2009-01-07 AR ARP090100037A patent/AR070120A1/es unknown
- 2009-01-07 US US12/349,850 patent/US20090181932A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2009089237A1 (en) | 2009-07-16 |
US20090181932A1 (en) | 2009-07-16 |
AR070120A1 (es) | 2010-03-17 |
PA8811701A1 (es) | 2009-08-26 |
TW200934482A (en) | 2009-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2018000257A (es) | Piridinas sustituidas con heteroarilo y métodos de uso | |
CL2018001223A1 (es) | Locus óptimo de la soja (divisional de solicitud 201601063) | |
CU20170015A7 (es) | Compuesto de (pirazolilamino) pirimidinil biciclo (3.2.1)oct-8-il | |
NI201700095A (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
AR093244A1 (es) | Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2 | |
BR112015001502A2 (pt) | derivados de tipo azaindazol ou diazaindazol para tratamento de dor | |
CL2013003313A1 (es) | Compuestos derivados de 2,4-diaminoquinazolinas, sales o solvatos farmacéuticamente aceptables; composición farmacéutica que los comprende; y uso en el tratamiento de un trastorno en el que interviene la modulación de tlr7 y/o tlr8. | |
NI201800128A (es) | Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos | |
CR20140399A (es) | Pirrolidina-2-carboxamidas sustituidas | |
PE20151495A1 (es) | Compuestos de pirrolopirimidina como inhibidores de quinasas | |
CU20160052A7 (es) | Amino-heteroaril-benzamidas como inhibidores de cinasa | |
UY36702A (es) | Piridinas sustituidas y métodos de uso | |
CR20120414A (es) | Derivados de arilmetoxi isoindolina y composiciones que los comprenden y métodos para utilizar los mismos | |
UY31918A (es) | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento | |
UY36713A (es) | Triazoles para el tratamiento de enfermedades desmielinizantes | |
DOP2018000062A (es) | Piridinona dicaboxamidas para uso como inhibidores de bromodominio | |
BR112014000792A2 (pt) | compostos de piperidinila para uso como inibidores da tanquirase | |
UY33817A (es) | ?nuevas oxindolpirimidinas bencílicas?. | |
CO2019012767A2 (es) | Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo | |
CO7101239A2 (es) | Composiciones derivadas de la quitosana | |
UY32359A (es) | Compuestos de plasmalogenos, composiciones farmaceuticas que los contienen y metodos para tratar enfermedades del envejecimiento | |
CR11842A (es) | Compuestos de sulfoximinamida para combatir animales plaga | |
CL2021001388A1 (es) | Compuestos útiles en la terapia para el vih | |
ECSP11010807A (es) | Sales de los compuestos del inhibidor de vih | |
GT201400242A (es) | "nuevos compuestos de pirazol" |